UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Advances in molecular classification and precision oncology in hepatocellular carcinoma

Journal of hepatology, 2020-02, Vol.72 (2), p.215-229

2020

Volltextzugriff (PDF)

The role of telomeres and telomerase in cirrhosis and liver cancer

Nature reviews. Gastroenterology & hepatology, 2019-09, Vol.16 (9), p.544

2019

Volltextzugriff (PDF)

Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma

Journal of hepatology, 2008-01, Vol.48 (1), p.163-170

2008

Volltextzugriff (PDF)

A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis

Cancer research (Chicago, Ill.), 2015-10, Vol.75 (19), p.4042-4052

2015

Volltextzugriff (PDF)

Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2020-01, Vol.71 (1), p.164-182

2020

Volltextzugriff (PDF)

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype

Science translational medicine, 2014-07, Vol.6 (244), p.244ra91

2014

Volltextzugriff (PDF)

Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry

Hepatology (Baltimore, Md.), 2007-09, Vol.46 (3), p.740-748

2007

Volltextzugriff (PDF)

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

Hepatology (Baltimore, Md.), 2007-01, Vol.45 (1), p.42-52

2007

Volltextzugriff (PDF)

Independent Component Analysis Uncovers the Landscape of the Bladder Tumor Transcriptome and Reveals Insights into Luminal and Basal Subtypes

Cell reports (Cambridge), 2014-11, Vol.9 (4), p.1235-1245

2014

Volltextzugriff (PDF)

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro

Clinical cancer research, 2017-08, Vol.23 (15), p.4364-4375

2017

Volltextzugriff (PDF)

Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma

Nature communications, 2023-11, Vol.14 (1), p.7122-7122, Article 7122

2023

Volltextzugriff (PDF)

PI3K/AKT pathway activation in bladder carcinogenesis

International journal of cancer, 2014-04, Vol.134 (8), p.1776-1784

2014

Volltextzugriff (PDF)

Recurrent activating mutations of PPARγ associated with luminal bladder tumors

Nature communications, 2019-01, Vol.10 (1), p.253-253, Article 253

2019

Volltextzugriff (PDF)

APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures

Oncoimmunology, 2019-06, Vol.8 (6), p.e1583547-e1583547

2019

Volltextzugriff (PDF)

Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver

Gastroenterology (New York, N.Y. 1943), 2005-05, Vol.128 (5), p.1211-1218

2005

Volltextzugriff (PDF)

Sigma 1 Receptor is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α

Cancers, 2020-08, Vol.12 (8), p.2213

2020

Volltextzugriff (PDF)

HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines

BMC cancer, 2011-10, Vol.11 (1), p.427-427, Article 427

2011

Volltextzugriff (PDF)

Genotype phenotype classification of hepatocellular adenoma

World journal of gastroenterology : WJG, 2007-05, Vol.13 (19), p.2649

2007

Volltextzugriff (PDF)

Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas

Journal of hepatology, 2004-08, Vol.41 (2), p.292-298

2004

Volltextzugriff (PDF)

Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression

Hepatology (Baltimore, Md.), 2016-12, Vol.64 (6), p.2047-2061

2016

Volltextzugriff (PDF)

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response

Gastroenterology (New York, N.Y. 1943), 2019-09, Vol.157 (3), p.760-776

2019

Volltextzugriff (PDF)

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study

The lancet oncology, 2022-01, Vol.23 (1), p.161-171

2022

Volltextzugriff (PDF)

Note of caution: Contaminations of hepatocellular cell lines

Journal of hepatology, 2017-11, Vol.67 (5), p.896-897

2017

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(79)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(46)
Science & Technology
(45)
Life Sciences & Biomedicine
(42)
Life Sciences
(34)
Mutation
(31)
Female
(26)
Liver Neoplasms - Genetics
(25)
Gastroenterology & Hepatology
(23)
Male
(23)
Human Health And Pathology
(20)
Tumors
(19)
Cancer
(18)
Carcinoma, Hepatocellular - Genetics
(18)
Adult
(17)
Hépatology And Gastroenterology
(17)
Middle Aged
(17)
Liver Cancer
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Hepatocellular Carcinoma
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in molecular classification and precision oncology in hepatocellular carcinoma

The role of telomeres and telomerase in cirrhosis and liver cancer

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma

A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis

Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype

Dual Targeting of Histone Methyltransferase G9a and DNA‐Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma

Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

Independent Component Analysis Uncovers the Landscape of the Bladder Tumor Transcriptome and Reveals Insights into Luminal and Basal Subtypes

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro

Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma

PI3K/AKT pathway activation in bladder carcinogenesis

Recurrent activating mutations of PPARγ associated with luminal bladder tumors

APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures

Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver

Sigma 1 Receptor is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α

HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines

Genotype phenotype classification of hepatocellular adenoma

Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas

Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study

Note of caution: Contaminations of hepatocellular cell lines

Suchergebnisse filtern